Bronnen somatisatiestoornis en hypochondrie

Briquet, P. (1859). Traité clinique et thérapeutique de l'hystérie. Paris: Baillière.
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders [DSM-IV-TR]. Washington, DC: American Psychiatric Association.
Barsky, A.J., Barnett, M.C., Cleary, P.D. (1994). Hypochondriasis and panic disorder: boundary and overlap. Archives of General Psychiatry, 51(11): 918-925.
Hiller, W., Leibbrand, R., Rief, W., Fichter, M.M. (2005). Differentiating hypochondriasis from panic disorder. Journal of Anxiety Disorders, 19(1): 29-49.
Van der Feltz-Cornelis, C., Van der Horst, H. (2003). Handboek somatisatie: lichamelijk onverklaarde klachten in de eerste en tweede lijn. Utrecht: De Tijdstroom.
Van der Horst, H. (2003). Somatisatie, een veelzijdig fenomeen. In: C. Van der Feltz-Cornelis, H. Van der Horst (red.). Handboek somatisatie: lichamelijk onverklaarde klachten in de eerste en tweede lijn, p. 15-27. Utrecht: De Tijdstroom.
Sar, V., Akyuz, G., Kundakci, T., Kiziltan, E., Dogan, O. (2004). Childhood trauma, dissociation, and psychiatric comorbidity in patiënt s with conversion disorder. American Journal of Psychiatry, 161(12): 2271-2276.
Brown, R.J., Schrag, A., Trimble, M.R. (2005). Dissociation, childhood interpersonal trauma, and family functioning in patiënt s with somatization disorder. American Journal of Psychiatry, 162(5): 899-905.
North, C.S. (2002). Somatization in survivors of catastrophic trauma: a methodological review. Environental Health Perspectectives, 110 Suppl 4(637-640).
North, C.S., Kawasaki, A., Spitznagel, E.L., Hong, B.A. (2004). The course of PTSD, major depression, substance abuse, and somatization after a natural disaster. Journal of Nervous & Mental Disease, 192(12): 823-829.
Gureje, O., Simon, G.E. (1999). The natural history of somatization in primary care. Psychological Medicine, 29(3): 669-676.
Noyes, R., Jr., Kathol, R.G., Fisher, M.M., Phillips, B.M., Suelzer, M.T., Woodman, C.L. (1994). Psychiatric comorbidity among patiënt s with hypochondriasis. General Hospital Psychiatry, 16(2): 78-87.
Henningsen, P., Jakobsen, T., Schiltenwolf, M., Weiss, M.G. (2005). Somatization revisited: diagnosis and perceived causes of common mental disorders. Journal of Nervous & Mental Disease, 193(2): 85-92.
Garyfallos, G., Adamopoulou, A., Karastergiou, A., Voikli, M., Ikonomidis, N., Donias, S., Giouzepas, J., Dimitriou, E. (1999). Somatoform disorders: comorbidity with other DSM-III-R psychiatric diagnoses in Greece. Comprehensive Psychiatry, 40(4): 299-307.
Lipsanen, T., Saarijarvi, S., Lauerma, H. (2004). Exploring the relations between depression, somatization, dissociation and alexithymia: overlapping or independent constructs? Psychopathology, 37(4): 200-206.
Barsky, A.J., Borus, J.F. (1999). Functional somatic syndromes. Annals of Internal Medicine, 130(11): 910-921.
Blankenstein, A.H. (2003). Reattributie in de huisartsenpraktijk. In: C.Van der Feltz-Cornelis, H.Van der Horst (red.). Handboek somatisatie: lichamelijk onverklaarde klachten in de eerste en tweede lijn, p. 55-70. Utrecht: De Tijdstroom.
Smith, G.C. (2003). The future of consultation-liaison psychiatry. Australian and New Zealand Journal of Psychiatry, 37(2): 150-159.
Shaw, J., Creed, F. (1991). The cost of somatization. Journal of Psychosomatic Research, 35(2-3): 307-312.
Smith, G.R., Jr., Monson, R.A., Ray, D.C. (1986). Patiënt s with multiple unexplained symptoms: their characteristics, functional health, and health care utilization. Archives of Internal Medicine, 146(1): 69-72.
Reid, S., Wessely, S., Crayford, T., Hotopf, M. (2002). Frequent attenders with medically unexplained symptoms: service use and costs in secondary care. British Journal of Psychiatry, 180(March): 248-253.
Michaud, C.M., Murray, C.J., Bloom, B.R. (2001). Burden of disease: implications for future research. JAMA, 285(5): 535-539.
Murray, C.J., Lopez, A.D. (1996). Evidence-based health policy: lessons from the Global Burden of Disease Study. Science, 274(5288): 740-743.
Mayou, R., Sharpe, M. (1995). Patiënt s whom doctors find difficult to help: an important and neglected problem. Psychosomatics, 36(4): 323-325.
Mayou, R. (1993). Somatization. Psychotherapy and Psychosomatics, 59(2): 69-83.
Simon, G.E., VonKorff, M., Piccinelli, M., Fullerton, C., Ormel, J. (1999). An international study of the relation between somatic symptoms and depression. New England Journal of Medicine, 341(18): 1329-1335.
Miller, G.E., Freedland, K.E., Carney, R.M., Stetler, C.A., Banks, W.A. (2003). Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behavior and Immunity, 17(4): 276-285.
Gerber, P.D., Barrett, J.E., Barrett, J.A., Oxman, T.E., Manheimer, E., Smith, R., Whiting, R.D. (1992). The relationship of presenting physical complaints to depressive symptoms in primary care patiënt s. Journal of General Internal Medicine, 7(2): 170-173.
Kirmayer, L.J., Robbins, J.M., Dworkind, M., Yaffe, M.J. (1993). Somatization and the recognition of depression and anxiety in primary care. American Journal of Psychiatry, 150(5): 734-741.
Henningsen, P., Zimmermann, T., Sattel, H. (2003). Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosomatic Medicine, 65(4): 528-533.
Kooiman, C.G., Bolk, J.H., Rooijmans, H.G., Trijsburg, R.W. (2004). Alexithymia does not predict the persistence of medically unexplained physical symptoms. Psychosomatic Medicine, 66(2): 224-232.
Waller, E., Scheidt, C.E. (2004). Somatoform disorders as disorders of affect regulation: a study comparing the TAS-20 with non-self-report measures of alexithymia. Journal of Psychosomatic Research, 57(3): 239-247.
Sifneos, P.E. (1973). The prevalence of 'alexithymic' characteristics in psychosomatic patiënt s. Psychotherapy and Psychosomatics, 22(2): 255-262.
Kiecolt-Glaser, J.K., McGuire, L., Robles, T.F., Glaser, R. (2002). Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosomatic Medicine, 64(1): 15-28.
Kronfol, Z., Remick, D.G. (2000). Cytokines and the brain: implications for clinical psychiatry. American Journal of Psychiatry, 157(5): 683-694.
Plata-Salaman, C., Turrin, N. (1999). Cytokine interactions and cytokine balance in the brain: relevance to neurology and psychiatry. Molecular Psychiatry, 4(4): 302-306.
Viljoen, M., Panzer, A. (2005). Non-termination of sickness behavior as precipitating factor for mental disorders. Medical Hypotheses, 65(2): 316-329.
Vollmer-Conna, U., Fazou, C., Cameron, B., Li, H., Brennan, C., Luck, L., Davenport, T., Wakefield, D., Hickie, I., Lloyd, A. (2004). Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychological Medicine, 34(7): 1289-1297.
Dunn, A.J., Swiergiel, A.H., de Beaurepaire, R. (2005). Cytokines as mediators of depression: what can we learn from animal studies? Neuroscience and Biobehavioral Reviews, 29(4-5): 891-909.
De La Garza, R. (2005). Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neuroscience and Biobehavioral Reviews, 29(4-5): 761-770.
Anisman, H., Merali, Z., Poulter, M.O., Hayley, S. (2005). Cytokines as a precipitant of depressive illness: animal and human studies. Current Pharmaceutical Design, 11(8): 963-972.
Banks, W.A., Farr, S.A., Morley, J.E. (2002). Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation, 10(6): 319-327.
O'Brien, S.M., Scott, L.V., Dinan, T.G. (2004). Cytokines: abnormalities in major depression and implications for pharmacological treatment. Human Psychopharmacology, 19(6): 397-403.
Schiepers, O.J., Wichers, M.C., Maes, M. (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29(2): 201-217.
Stern, T.A., Fricchione, G.L., Cassem, N.H., Jellinek, M., Rosenbaum, J.F. (2004). General hospital handbook of general hospital psychiatry. Massachusetts: Mosby.
Becker, S., Al Zaid, K., Al Faris, E. (2002). Screening for somatization and depression in Saudi Arabia: a validation study of the PHQ in primary care. International Journal of Psychiatry Medicine, 32(3): 271-283.
Spitzer, R.L., Kroenke, K., Williams, J.B. (1999). Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patiënt Health Questionnaire. JAMA, 282(18): 1737-1744.
Speckens, A.E., van Hemert, A.M., Spinhoven, P., Bolk, J.H. (1996). The diagnostic and prognostic significance of the Whitely Index, the Illness Attitude Scales and the Somatosensory Amplification Scale. Psychological Medicine, 26(5): 1085-1090.
Speckens, A.E., Spinhoven, P., Sloekers, P.P., Bolk, J.H., van Hemert, A.M. (1996). A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patiënt s. Journal of Psychosomatic Research, 40(1): 95-104.
Barsky, A.J., Ahern, D.K. (2004). Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA, 291(12): 1464-1470.
Larisch, A., Schweickhardt, A., Wirsching, M., Fritzsche, K. (2004). Psychosocial interventions for somatizing patiënt s by the general practitioner: a randomized controlled trial. Journal of Psychosomatic Research, 57(6): 507-514.
Clark, D.M., Salkovskis, P.M., Hackmann, A., Wells, A., Fennell, M., Ludgate, J., Ahmad, S., Richards, H.C., Gelder, M. (1998). Two psychological treatments for hypochondriasis: a randomised controlled trial. British Journal of Psychiatry, 173(September): 218-225.
Van der Feltz-Cornelis, C.M., van Oppen, P., Adèr, H.J., Van Dyck, R. (2006). Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychotherapy and Psychosomatics. (In press)
Bouman, T.K., Visser, S. (1998). Cognitive and behavioural treatment of hypochondriasis. Psychotherapy and Psychosomatics, 67(4-5): 214-221.
Sumathipala, A., Hewege, S., Hanwella, R., Mann, A.H. (2000). Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka. Psychological Medicine, 30(4): 747-757.
Speckens, A.E.M., van Hemert, A.M., Spinhoven, P., Hawton, K.E., Rooijmans, H.G.M. (1996). Gunstige effecten van cognitieve gedragstherapie voor onverklaarde lichamelijke klachten: een gerandomiseerd onderzoek. Nederlands Tijdschrift voor Geneeskunde, 140(23): 1227-1232.
Smith, G.R., Jr., Monson, R.A., Ray, D.C. (1986). Psychiatric consultation in somatization disorder: a randomized controlled study. New England Journal of Medicine, 314(22): 1407-1413.
Dickinson, W.P., Dickinson, L.M., deGruy, F.V., Main, D.S., Candib, L.M., Rost, K. (2003). A randomized clinical trial of a care recommendation letter intervention for somatization in primary care. Annals of Family Medicine, 1(4): 228-235.
Smith, G.R., Jr., Rost, K., Kashner, T.M. (1995). A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patiënt s. Archives of General Psychiatry, 52(3): 238-243.
Rost, K., Kashner, T.M., Smith, R.G., Jr. (1994). Effectiveness of psychiatric intervention with somatization disorder patiënt s: improved outcomes at reduced costs. General Hospital Psychiatry, 16(6): 381-387.
Kashner, T.M., Rost, K., Cohen, B., Anderson, M., Smith, G.R., Jr. (1995). Enhancing the health of somatization disorder patiënt s: effectiveness of short-term group therapy. Psychosomatics, 36(5): 462-470.
Bleichhardt, G., Timmer, B., Rief, W. (2004). Cognitive-behavioural therapy for patiënt s with multiple somatoform symptoms: a randomised controlled trial in tertiary care. Journal of Psychosomatic Research, 56(4): 449-454.
Van der Feltz-Cornelis, C.M., van Oppen, P., Adèr, H.J., Van Dyck, R. (2006). Randomised trial of collaborative care for somatoform disorder in general practice. Psychotherapy and Psychosomatics. (In press)
Tavola, T., Gala, C., Conte, G., Invernizzi, G. (1992). Traditional Chinese acupuncture in tension-type headache: a controlled study. Pain, 48(3): 325-329.
Aragona, M., Bancheri, L., Perinelli, D., Tarsitani, L., Pizzimenti, A., Conte, A., Inghilleri, M. (2005). Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatiënt s with somatoform, DSM-IV-TR pain disorder. European Journal of Pain, 9(1): 33-38.
Mitsikostas, D.D., Gatzonis, S., Thomas, A., Ilias, A. (1997). Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurologica Scandinavica, 96(4): 247-251.
Turkington, D., Grant, J.B., Ferrier, I.N., Rao, N.S., Linsley, K.R., Young, A.H. (2002). A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder. Journal of Clinical Psychiatry, 63(9): 778-781.
Payne, A., Blanchard, E.B. (1995). A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. Journal of Consulting and Clinical Psychology, 63(5): 779-786.
Guthrie, E., Creed, F., Dawson, D., Tomenson, B. (1993). A randomised controlled trial of psychotherapy in patiënt s with refractory irritable bowel syndrome. British Journal of Psychiatry, 163(September): 315-321.
Mayou, R.A., Bryant, B.M., Sanders, D., Bass, C., Klimes, I., Forfar, C. (1997). A controlled trial of cognitive behavioural therapy for non-cardiac chest pain. Psychological Medicine, 27(5): 1021-1031.
Muller, T., Mannel, M., Murck, H., Rahlfs, V.W. (2004). Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial. Psychosomatic Medicine, 66(4): 538-547.
Volz, H.P., Murck, H., Kasper, S., Moller, H.J. (2002). St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Psychopharmacology, 164(3): 294-300.
Peveler, R., Katona, C., Wessely, S., Dowrick, C. (2006). Painful symptoms in depression: under-recognised and under-treated? British Journal of Psychiatry, 188(March): 202-203.
Katon, W., Von Korff, M., Lin, E., Bush, T., Russo, J., Lipscomb, P., Wagner, E. (1992). A randomized trial of psychiatric consultation with distressed high utilizers. General Hospital Psychiatry, 14(2): 86-98.
Kolk, A.M., Schagen, S., Hanewald, G.J. (2004). Multiple medically unexplained physical symptoms and health care utilization: outcome of psychological intervention and patiënt-related predictors of change. Journal of Psychosomatic Research, 57(4): 379-389.
Schilte, A.F., Portegijs, P.J., Blankenstein, A.H., Der Horst, H.E., Latour, M.B., van Eijk, J.T., Knottnerus, J.A. (2001). Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. British Medical Journal, 323(7304): 86
Peters, S., Stanley, I., Rose, M., Kaney, S., Salmon, P. (2002). A randomized controlled trial of group aerobic exercise in primary care patiënt s with persistent, unexplained physical symptoms. Family Practice, 19(6): 665-674.
Moene, F.C., Spinhoven, P., Hoogduin, K.A., Van Dyck, R. (2003). A randomized controlled clinical trial of a hypnosis-based treatment for patiënt s with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis, 51(1): 29-50.
Van Rood, Y., Visser, S. (2003). Principes van cognitieve gedragstherapie bij patiënt en met een somatoforme stoornis in de GGZ. In: C.Van der Feltz-Cornelis, H.Van der Horst (red.). Handboek somatisatie: lichamelijk onverklaarde klachten in de eerste en tweede lijn, p. 199-211. Utrecht: De Tijdstroom.
Blankenstein, A.H. (2001). Somatising patiënt s in general practice: reattribution, a promising approach. Amsterdam: Vrije Universiteit.
Speckens, A.E.M., Spinhoven, P., Van Rood, Y. (1999). Protocollaire behandeling van patiënten met onverklaarde lichamelijke klachten: cognitieve gedragstherapie. In: G.P.J.Keijsers, A.Van Minnen, C.A.L.Hoogduin (red.). Protocollaire behandelingen in de ambulante geestelijke gezondheidszorg: 2, p. 199-236. Houten; Diegem: Bogh Stafleu Van Loghum.
Visser, S., Bouman, T.K. (2001). The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behaviour Research & Therapy, 39(4): 423-442.
Visser, S., Bouman, T.K. (1992). Cognitive-behavioural approaches in the treatment of hypochondriasis: six single case cross-over studies. Behaviour Research & Therapy, 30(3): 301-306.
Warwick, H.M., Clark, D.M., Cobb, A.M., Salkovskis, P.M. (1996). A controlled trial of cognitive-behavioural treatment of hypochondriasis. British Journal of Psychiatry, 169(2): 189-195.